|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Marine ecoregions of the world:a bioregionalization of coastal and shelf areas显示文摘 | Spalding MD Fox HE Allen GR Davidson N Ferdafia ZA Finlayson M Halpern BS Jorge MA Lombana AL Lourie SA Martin KD Manus EC Molnar J Recchia CA Robertson J | | 0，，： | 1 |
| 2 | Platelet-rich plasma has no effect on increasing free fat graft survival in the nude mouse 显示文摘 | Por YC Yeow VK Louri N | 2009 | J Plast Reconstr Aesthet Surg2009，62，8： | 1 |
| 3 | Instrumentation, applications and energy deposi- tion in quadrupole ion-trap tandem mass-spee- trometry显示文摘 | LOURIS J N COOKS R G SYKA J E P | 1987 | Analytical Chemistry1987，59，13： | 1 |
| 4 | Death risk in hemodialysis patients: the predictive value of commonly measured variables and evaluation of death rate differences between facilities 显示文摘 | LOURIE E G LEW N L | 1990 | Am J Kidney Dis1990，15，5： | 1 |
| 5 | Platelet-rich plasma has no effect on increasing free fat graft survival in the nude mouse显示文摘 | Por YC Yeow VK Louri N | 2009 | J Plast Reconstr Aesthet Surg2009，62，8： | 1 |
| 6 | Tuberculous effusion: ADA activity correlates with CD4 + cell numbers in the fluid and the pleura 显示文摘 | Gaga M Papamichalis G Bakakos P Latsi P Samara I Kou louris NG Alchanatis N Orphanidou D | 2005 | Respiration2005，72，2： | 1 |
| 7 | Ion isolation and sequential stages of mass-spectrometry in aquadrupole ion trap mass- spectrometer显示文摘 | LOURIS J N BRODBELT-LUSTIG J S COOKS R G | 1990 | International Journal of Mass Spectrometry and Ion Processes1990，96，2： | 1 |
| 8 | Platelet-rich plasma has no effect on increasing free fat graft survival in the nude mouse 显示文摘 | Por YC Yeow VK Louri N | 2009 | J Plast Reconstr Aesthet Surg2009，62，8： | 1 |
| 9 | Platelet-rich plasma has no effect on increasing free fat graft survival in the nude mouse显示文摘 | Por Y Yeow V K Louri N | 2009 | J Plast Reconstr Aesthet Surg2009，62，： | 1 |
| 10 | Platelet-rich plasma has noeffect on increasing free fat graft survival in the nude mouse显示文摘 | Por YC Yeow VK Louri N | | 0，，08： | 1 |
| 11 | Corporate Performance : Does Ownership Matter? A Comparison of Foreign - and Domestic - owned Firms in Greece and Portugal显示文摘 | Barbosa N Louri H | 2005 | Review of Industrial Organization2005，27，1： | 1 |
| 12 | Platelet-rich plasma has no effect on increasing free fat graft survival in the nude mouse显示文摘 | Por YC Yeow VK Louri N | | 0，，08： | 1 |
| 13 | Platelet-rich plasma has no effect on increasing free fat graft survival in the nude mouse显示文摘 | Por YC Yeow VK Louri N | | 0，，08： | 1 |
| 14 | Neutrophil-to-lymphocyte ratio as a prognostic factor for survival in patients with colorectal liver metastases: A systematic review显示文摘BACKGROUND The inflammatory response to tumor has been proven to be closely related to the prognosis of colorectal cancer.Neutrophil to lymphocyte ratio(NLR)is a widely available inflammatory biomarker that may have prognostic value for patients with colorectal liver metastasis(CRLM).AIM To assess the role of NLR as a prognostic factor of survival and tumor recurrence in patients with CRLM.METHODS A systematic literature search of PubMed,Cochrane Library and clinicaltrials.gov was conducted by two independent researchers in order to minimize potential errors and bias.Conflicts were discussed and settled between three researchers.Studies including patients undergoing different types of medical interventions for the treatment of CRLM and evaluating the correlation between pretreatment NLR and disease-free survival(DFS)and overall survival(OS)were included in the review.Nineteen studies,involving 3283 patients matched our inclusion criteria.RESULTS In the studies included,NLR was measured before the intervention and the NLR thresholds ranged between 1.9 and 7.26.Most studies used 5 as the cut-off value.Liver metastases were treated with hepatectomy with or without chemotherapy regimens in 13 studies and with radiofrequency ablation,radioembolization,chemoembolization or solely with chemotherapy in 6 studies.High NLR was associated with decreased OS and DFS after liver resection or other medical intervention.Moreover,high NLR was associated with poor chemosensitivity.On the contrary,CRLM patients with low pretreatment NLR demonstrated improved OS and DFS.NLR could potentially be used as a predictive factor of survival and tumor recurrence in patients with CRLM treated with interventions of any modality,including surgery,chemotherapy and ablative techniques.CONCLUSION NLR is an inflammatory biomarker that demonstrates considerable prognostic value.Elevated pretreatment NLR is associated with poor OS and DFS in patients with CRLM who are submitted to different treatments. | Menelaos Papakonstantinou Stylianos Fiflis Gregory Christodoulidis Mariano Cesare Giglio Eleni Louri Savvas Mavromatidis Dimitrios Giakoustidis Vasileios N Papadopoulos Alexandros Giakoustidis | 2022 | World Journal of Clinical Oncology2022，13，10： | 0 |
| 15 | Median arcuate ligament syndrome often poses a diagnostic challenge: A literature review with a scope of our own experience显示文摘The median arcuate ligament syndrome(MALS)is recognized as a rare clinical entity,characterized by chronic post-prandial abdominal pain,nausea,vomiting,and unintentional weight loss.Due to its vague symptomatology,it is mainly regarded as a diagnosis of exclusion.Patients can often be misdiagnosed for several years before a correct diagnosis is established,also due to a medical team’s clinical suspicion.We present a case series of two patients who suffered from MALS and were treated successfully.The first patient is a 32-year-old woman,presenting with post-prandial abdominal pain and weight loss that have lasted for the past ten years.The second patient,a 50-year-old woman,presented with similar symptomatology,with the symptoms lasting for the last five years.Both cases were treated by laparoscopic division of the median arcuate ligament fibers,which alleviated extrinsic pressure from the celiac artery.Previous cases of MALS were retrieved from PubMed,to assemble a better diagnostic algorithm and propose a treatment method of choice.The literature review suggests an angiography with a respiratory variation protocol as the diagnostic modality of choice,along with the laparoscopic division of the median arcuate ligament fibers as the proposed treatment of choice. | Alexandros Giakoustidis Stavros Moschonas Gregory Christodoulidis Danae Chourmouzi Anna Diamantidou Sophia Masoura Eleni Louri Vasileios N Papadopoulos Dimitrios Giakoustidis | 2023 | World Journal of Gastrointestinal Surgery2023，15，6： | 0 |
| 16 | Comparison between upfront surgery and neoadjuvant chemotherapy in patients with locally advanced gastric cancer:A systematic review显示文摘BACKGROUND Gastric cancer(GC)is a major health concern worldwide.Surgical resection and chemotherapy is the mainstay treatment for gastric carcinoma,however,the optimal approach remains unclear and should be different in each individual.Chemotherapy can be administered both pre-and postoperatively,but a multidisciplinary approach is preferred when possible.This is particularly relevant for locally advanced GC(LAGC),as neoadjuvant chemotherapy(NAT)could potentially lead to tumor downsizing thus allowing for a complete resection with curative intent.Even though the recent progress has been impressive,European and International guidelines are still controversial,thus attenuating the need for a more standardized approach in the management of locally advanced cancer.AIM To investigate the effects of NAT on the overall survival(OS),the disease-free survival(DFS),the morbidity and the mortality of patients with LAGC in comparison to upfront surgery(US).METHODS For this systematic review,a literature search was conducted between November and February 2023 in PubMed,Cochrane Library and clinicaltrials.gov for studies including patients with LAGC.Two independent reviewers conducted the research and extracted the data according to predetermined inclusion and exclusion criteria.The Preferred Reporting Items for Systematic Reviews and Meta-Analyses was used to form the search strategy and the study protocol has been registered in the International Prospective Register of Systematic Reviews.RESULTS Eighteen studies with 4839 patients with LAGC in total were included in our systematic review.Patients were separated into two groups;one receiving NAT before the gastrectomy(NAT group)and the other undergoing upfront surgery(US group).The OS ranged from 41.6%to 74.2%in the NAT group and from 30.9%to 74%in the US group.The DFS was also longer in the NAT group and reached up to 80%in certain patients.The complications related to the chemotherapy or the surgery ranged from 6.4%to 38.1%in the NAT group and from 5%to 40.5%in the US group.Even though in most of the studies the morbidity was lower in the NAT group,a general conclusion could not be drawn as it seems to depend on multiple factors.Finally,regarding the mortality,the reported rate was higher and up to 5.3%in the US group.CONCLUSION NAT could be beneficial for patients with LAGC as it leads to better OS and DFS than the US approach with the same or even lower complication rates.However,patients with different clinicopathological features respond differently to chemotherapy,therefore currently the treatment plan should be individualized in order to achieve optimal results. | Stylianos Fiflis Menelaos Papakonstantinou Alexandros Giakoustidis Gregory Christodoulidis Eleni Louri Vasileios N Papadopoulos Dimitrios Giakoustidis | 2023 | World Journal of Gastrointestinal Surgery2023，15，8： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员